Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

ADMA Biologics Inc - Common Stock (NQ:ADMA)

8.725 -0.025 (-0.29%)

Streaming Delayed Price Updated: 10:54 AM EDT, Jul 21, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	432,387
Open	8.685
Bid (Size)	8.720 (700)
Ask (Size)	8.730 (700)
Prev. Close	8.750
Today's Range	8.585 - 8.755
52wk Range	7.210 - 20.46
Shares Outstanding	196,357,149
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 20, 2026

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 20, 2026) - Kahn Swick & Foti, LLC ("KSF")...

Via Newsfile

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

July 20, 2026

From Schall Law

Via GlobeNewswire

Performance

YTD	-51.2%	-51.2%
1 Month	+1.8%	+1.8%
3 Month	-19.8%	-19.8%
6 Month	-50.4%	-50.4%
1 Year	-49.1%	-49.1%

More News

ADMA BIOLOGICS DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA

July 19, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 17, 2026

Via Newsfile

ADMA Biologics, Inc. Stock Drop: Robbins LLP Urges Investors to Contact the Firm for Information About the Class Action Against ADMA Biologics, Inc.

July 17, 2026

From Robbins LLP

Via Business Wire

ADMA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA

July 16, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

July 16, 2026

From SkyMedia, LLC

Via GlobeNewswire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ADMA Biologics, Inc. (ADMA)

July 16, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Insulet Corporation (NASDAQ: PODD); Intuit Inc. (INTU); and Power Solutions International, Inc. (NASDAQ: PSIX): Grabar Law Office is Investigating Claims on Your Behalf

July 16, 2026

From Grabar Law Office

Via GlobeNewswire

ADMA Fraud Notice: ADMA Biologics Investors are Reminded to Contact BFA Law about the Filed Securities Fraud Class Action Lawsuit to Recover Investment Losses

July 16, 2026

From Bleichmar Fonti & Auld LLP

Via Business Wire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 14, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines – ADMA

July 14, 2026

From Pomerantz LLP

Via GlobeNewswire

Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); Commvault Systems, Inc. (NASDAQ: CVLT); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law Office is Investigating Claims on Your Behalf

July 14, 2026

From Grabar Law Office

Via GlobeNewswire

ADMA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026

July 11, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

July 10, 2026

From Schall Law

Via GlobeNewswire

ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

July 09, 2026

From SkyMedia, LLC

Via GlobeNewswire

INVESTOR DEADLINE ALERT: ADMA Biologics, Inc. (ADMA) Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

July 09, 2026

Via NewMediaWire

INVESTOR DEADLINE ALERT: ADMA Biologics, Inc. (ADMA) Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit

July 09, 2026

Via TheNewswire.com

ADMA Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in ADMA BIOLOGICS, INC. Securities Lawsuit - Contact Levi & Korsinsky

July 09, 2026

From Levi & Korsinsky, LLP

Via Business Wire

ADMA BIOLOGICS, INC. (ADMA) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds ADMA Biologics, Inc. Investors of Upcoming Deadline

July 09, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 08, 2026

Via Newsfile

REMINDER: ADMA Biologics, Inc. Investors With Significant Losses Must Act By August 10, 2026 – Kirby McInerney LLP

July 08, 2026

From Kirby McInerney LLP

Via GlobeNewswire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 07, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines – ADMA

July 07, 2026

From Pomerantz LLP

Via GlobeNewswire

ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA

July 07, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

Frequently Asked Questions

Is ADMA Biologics Inc - Common Stock publicly traded?

Yes, ADMA Biologics Inc - Common Stock is publicly traded.

What exchange does ADMA Biologics Inc - Common Stock trade on?

ADMA Biologics Inc - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for ADMA Biologics Inc - Common Stock?

The ticker symbol for ADMA Biologics Inc - Common Stock is ADMA on the Nasdaq Stock Market

What is the current price of ADMA Biologics Inc - Common Stock?

The current price of ADMA Biologics Inc - Common Stock is 8.725

When was ADMA Biologics Inc - Common Stock last traded?

The last trade of ADMA Biologics Inc - Common Stock was at 07/21/26 10:54 AM ET

What is the market capitalization of ADMA Biologics Inc - Common Stock?

The market capitalization of ADMA Biologics Inc - Common Stock is 1.71B

How many shares of ADMA Biologics Inc - Common Stock are outstanding?

ADMA Biologics Inc - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433